PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
CAPG 85 Target Target DJ-1/PARK7 21 1 0.02 -0.97 0.05 0.78
Parkinsons Disease 124 Disease Target DJ-1/PARK7 21 1 0.02 -0.97 0.05 0.76
Dandruff 360 Disease Disease Cradle Cap 21 1 0.01 -0.97 0.05 0.72
Seborrhea 430 Disease Disease Cradle Cap 21 1 0.01 -0.97 0.05 0.72
AXL 633 Target Target Alpha Platelet-Derived Growth Factor Receptor 21 1 0.01 -0.98 0.05 0.70
CNTF 1,613 Target Target Alpha Platelet-Derived Growth Factor Receptor 21 1 0.01 -0.98 0.05 0.68
BNP 6,842 Target Target CAMK2B 21 1 0.00 -0.98 0.05 0.64
Skin Disease 6,955 Disease Drug Alefacept (Amevive)- FDA 21 1 0.00 -0.98 0.05 0.63
Skin Disease 6,955 Disease Drug Amevive (Alefacept)- FDA 21 1 0.00 -0.98 0.05 0.63
Respiratory Tract Infections 9,721 Disease Disease Cradle Cap 21 1 0.00 -0.98 0.05 0.63
Hormone Replacement Therapy 11,020 Disease Target CAMK2D 21 1 0.00 -0.98 0.05 0.62
BDNF 11,163 Target Target DJ-1/PARK7 21 1 0.00 -0.98 0.05 0.62
Skin Cancer 11,561 Disease Drug Alefacept (Amevive)- FDA 21 1 0.00 -0.98 0.05 0.62
Skin Cancer 11,561 Disease Drug Amevive (Alefacept)- FDA 21 1 0.00 -0.98 0.05 0.62
Major Depressive Disorder 12,517 Disease Target CAMK2D 21 1 0.00 -0.98 0.05 0.62
Parkinsonism 13,164 Disease Target DJ-1/PARK7 21 1 0.00 -0.98 0.05 0.62
Drug Abuse 13,496 Disease Target CAMK2B 21 1 0.00 -0.98 0.05 0.62
Myeloperoxidase 16,181 Target Target Protein Fimh 21 1 0.00 -0.98 0.05 0.61
Hyperthyroidism 16,816 Disease Target CAMK2B 21 1 0.00 -0.98 0.05 0.61
ERK1 18,374 Target Target DJ-1/PARK7 21 1 0.00 -0.98 0.05 0.61
Hypoglycemia 20,698 Disease Target CAMK2D 21 1 0.00 -0.98 0.05 0.61
Inflammatory Bowel Disease 24,375 Disease Target Protein Fimh 21 1 0.00 -0.98 0.05 0.60
EGF 27,487 Target Target Protein Fimh 21 1 0.00 -0.98 0.05 0.60
Hearing Loss 30,622 Disease Target CAMK2B 21 1 0.00 -0.98 0.05 0.60
Ovarian Cancer 33,996 Disease Target AMY2B 21 1 0.00 -0.98 0.05 0.60
Ovarian Cancer 33,996 Disease Target CAMK2D 21 1 0.00 -0.98 0.05 0.60
Brain Injury 34,874 Disease Target CAMK2D 21 1 0.00 -0.98 0.05 0.60
Seizure 44,685 Disease Target CAMK2D 21 1 0.00 -0.98 0.05 0.59
Influenza 67,933 Disease Target CAMK2B 21 1 0.00 -0.98 0.05 0.58
Influenza 67,933 Disease Target Protein Fimh 21 1 0.00 -0.98 0.05 0.58
CD4 112,219 Target Target CAMK1D 21 1 0.00 -0.98 0.05 0.57
Obesity 138,233 Disease Target AMY2B 21 1 0.00 -0.98 0.05 0.57
Collagen 138,882 Target Target CAMK2B 21 1 0.00 -0.98 0.05 0.56
Stroke 146,992 Disease Target CAMK1D 21 1 0.00 -0.98 0.05 0.56
Stroke 146,992 Disease Target CAMK2D 21 1 0.00 -0.98 0.05 0.56
Cholesterol 182,390 Disease Target CAMK2B 21 1 0.00 -0.98 0.05 0.56
Depression 220,092 Disease Target CAMK2D 21 1 0.00 -0.98 0.05 0.56
Depression 220,092 Disease Target CAMK2B 21 1 0.00 -0.98 0.05 0.56
Inflammation 252,734 Disease Target Protein Fimh 21 1 0.00 -0.98 0.05 0.55
Diabetes 332,602 Disease Drug Alefacept (Amevive)- FDA 21 1 0.00 -0.98 0.05 0.55
Diabetes 332,602 Disease Drug Amevive (Alefacept)- FDA 21 1 0.00 -0.98 0.05 0.55
Carcinoma 433,099 Disease Target AMY2B 21 1 0.00 -0.98 0.05 0.54
Carcinoma 433,099 Disease Target CAMK1D 21 1 0.00 -0.98 0.05 0.54
Carcinoma 433,099 Disease Target DJ-1/PARK7 21 1 0.00 -0.98 0.05 0.54
Infection 766,637 Disease Target CAMK2D 21 1 0.00 -0.98 0.05 0.53
Cancer 1,053,491 Disease Drug Alefacept (Amevive)- FDA 21 1 0.00 -0.98 0.05 0.53
Cancer 1,053,491 Disease Drug Amevive (Alefacept)- FDA 21 1 0.00 -0.98 0.05 0.53
Acute Promyelocytic Leukemia 4,780 Disease Drug Ascorbic Acid (Vitamin C)- FDA 20 1 0.00 -0.97 0.05 0.65
Psychiatric Disorder 6,440 Disease Target Cyclooxygenase-3 20 1 0.00 -0.97 0.05 0.64
APOE 12,771 Target Target BRSK1 20 1 0.00 -0.97 0.05 0.62